Aarey Drugs & Pharmaceuticals LimitedAAREYDRUGSNSE
Aarey Drugs allots 11.5 lakh shares on warrant conversion
As filed · Aarey Drugs & Pharmaceuticals Limited has informed the Exchange about General Updates
CapitalMixedMinormateriality 45 out of 100
What happened
FactAarey Drugs and Pharmaceuticals approved the allotment of 11,50,000 equity shares following conversion of fully convertible warrants. The company received Rs. 47.85 per warrant, aggregating to Rs. 5,50,27,500, and its paid-up capital increased to 3,18,74,303 shares.
Why it matters
CapitSignal interpretationShares are issued to named investors at a set price, diluting existing holders and changing who sits on the register.
Watch next
Fact- Who the allottees are
- Issue price versus market price
- Lock-in period on the new shares
Evidence
How CapitSignal classified this
- Reasoning:
- The conversion raises additional equity capital and increases the share count. A further 14,80,000 warrants remain outstanding for potential conversion within the stated tenure.
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 90%